10th October 2024
Artificial Intelligence (AI) is revolutionising various industries, and pharmaceutical marketing is no exception.
Artificial Intelligence (AI) is revolutionising various industries, and pharmaceutical marketing is no exception.
In this illuminating video, Dr. Asif Qasim, consultant cardiologist and CEO of MedShr, shares expert advice for pharmaceutical marketers on how to effectively engage with healthcare professionals.
Our Digital Interest Group has put together a quick video showing the simple rules for success in supporting HCP’s.
Could the magical allure of a white rabbit really ignite a renewed perspective on who our customer truly is? Seemingly this is something which worked for Alice as she traversed her own Wonderland. This article is the third in the 2024 series produced by the Pharmaceutical Marketing Society’s Digital Interest Group.
This Pharmaceutical Marketing Society article is based on a recent discussion between three members of the Digital Interest Group.
This article provided an overview of various thought-provoking articles published by the PM Society Digital Interest Group (DIG) throughout 2023.
This article is the 13th in a series produced by the Digital Interest Group. It is an exciting time of year looking forward to next year’s projects with a new budget to spend, or perhaps quickly using up the remainder of this year’s budget before Scrooge in procurement takes it back.
This article is the 12th in a series produced by the Pharmaceutical Marketing Society’s Digital Interest Group.
Delivering relevant, valuable and timely content at scale to healthcare professionals (HCPs) still proves a challenge for many global companies.
But why?
The phrase “AI will not replace you, a person using it will” probably sums up how those working in #pharmamarketing and #medicalcommunications fields think about the acceleration we’ve seen in #AI since last November.